$WAT — AVOID 📊

$WAT — AVOID 📊 Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. 🎯 Q1 FY26 | Rev $1B | EPS $2.70 vs $2.31 🟢 💡 Consensus expects sustained high growth following the beat, but the variant view is that the beat may be partially one-time, and the market is overpricing future growth, with risk of multiple compression to sector norms (25–35x). 📉 Reward/Risk: 2.0:1 🏢 Business Quality: 8/10 - High-quality recurring revenue model with a strong competitive moat in analytical instruments, but sensitivity to pharma capex cycles. 📊 Valuation: rich - Trading at 46.4x P/E, well above health-care equipment peers (25–35x), with insufficient visibility to sustain this premium. 🔮 Catalyst: Recent Q1 2026 earnings beat 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/WAT0618 Also in play: $WTRG $AWK $CWT $SBS $XYL $MDU

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.